Biology Reference
In-Depth Information
References
1. Kuehnert, M. J., Kruszon-Moran, D., Hill, H. A., McQuillan, G., McAllister, S. K.,
Forsheim, G., McDougal, L. K., Chaitram, J., Jensen, B., Fridkin, S. K.,
Killgore, G., and Tenover, F. C. (2006) Prevalence of Staphylococcus aureus nasal
colonization in the United States, 2001-2002. J. Infect. Dis . 193 , 172-179.
2. Kluytmans, J., van Belkum, A., and Verbrugh, H. (1997) Nasal carriage of Staphy-
lococcus aureus : epidemiology, underlying mechanisms, and associated risks. Clin.
Microbiol. Rev . 10 , 505-520.
3. White, A. and Smith, J. (1963) Nasal reservoir as the source of extranasal staphy-
lococci. Antimicrob. Agents Chemother . 3 , 679-683.
4. Polgreen, P. M. and Herwaldt, L. A. (2004) Staphylococcus aureus colonization
and nosocomial infections: implications for prevention. Curr. Infect. Dis. Rep . 6 ,
435-441.
5. Yu, V. L., Goetz, A., Wagener, M., Smith, P. B., Rihs, J. D., Hanchett, J., and
Zuravleff, J. J. (1986) Staphylococcus aureus nasal carriage and infection in patients
on hemodialysis. N. Engl. J. Med . 315 , 91-96.
6. von Eiff, C., Becker, K., Machka, K., Stammer, H., and Peters, G. (2001) Nasal
carriage as a source of Staphylococcus aureus bacteremia. N. Engl. J. Med . 344 ,
11-16.
7. Corne, P., Marchandin, H., Jonquet, O., Campos, J., and Banuls, A.-L. (2005)
Molecular evidence that nasal carriage of Staphylococcus aureus plays a role in respi-
ratory tract infections of critically ill patients. J. Clin. Microbiol . 43 , 3491-3493.
8. Kowalski, T. J., Berbari, E. F., and Osmon, D. R. (2005) Epidemiology, treatment
and prevention of community-acquired methicillin-resistant Staphylococcus aureus
infections. Mayo Clin. Proc . 80 , 1201-1208.
9. Kluytmans, J. A., Mouton, J. W., Vandenbergh, M., Manders, M.-J., Maat, A.,
Wagenvoort, J., Michel, M., and Verbrugh, H. (1996) Reduction of surgical-site
infections in cardiothoracic surgery by elimination of nasal carriage of Staphylo-
coccus aureus . Infect. Control Hosp. Epidemiol . 17 , 780-785.
10. Perl, T., Cullen, J., Wenzel, R., Zimmerman, B., Pfaller, M., Sheppard, D.,
Twombley, J., French, P., and Herwalt, L. (2002) Intranasal mupirocin to prevent
postoperative Staphylococcus aureus infections. N. Engl. J. Med . 24 , 1871-1877.
11. Martin, J., Perdreau-Remington, F., Kartalija, M., Pasi, O., Webb, M.,
Gerberding, J., Chambers, H., Tauber, M., and Lee, B. (1999) A randomized clinical
trial of mupirocin in the eradication of Staphylococcus aureus nasal carriage in
human immunodeficiency virus disease. J. Infect. Dis . 180 , 896-899.
12. Wertheim, H. F. L., Vos, M. C., Ott, A., Voss, A., Kluytmans, J. A. J. W.,
Vandenbroucke-Grauls, C. M. J. E., Meester, M. H. M., van Keulen, P. H. J., and
Verbrugh, H. A. (2004) Mupirocin prophylaxis against nosocomial Staphylococcus
aureus infections in nonsurgical patients. Ann. Intern. Med . 140 , 419-425.
13. Yano, M., Doki, Y., Inoue, M., Tsujinaka, T., Shiozaki, H., and Monden, M.
(2000) Preoperative intranasal mupirocin ointment significantly reduces postoper-
ative infection with Staphylococcus aureus in patients undergoing upper gastroin-
testinal surgery. Surg. Today (Japan) 30 , 16-21.
Search WWH ::




Custom Search